Literature DB >> 11464222

Fas-ligand and immune privilege: the eyes have it.

T A Ferguson, D R Green.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11464222     DOI： 10.1038/sj.cdd.4400891

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN： 1350-9047            Impact factor:   15.828


× No keyword cloud information.
  8 in total

1.  Aqueous humor suppression of dendritic cell function helps maintain immune regulation in the eye during human uveitis.

Authors:  Alastair K Denniston; Paul Tomlins; Geraint P Williams; Sherine Kottoor; Imran Khan; Kadambari Oswal; Mike Salmon; Graham R Wallace; Saaeha Rauz; Philip I Murray; S John Curnow
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-21       Impact factor: 4.799

2.  Age-dependent changes in FasL (CD95L) modulate macrophage function in a model of age-related macular degeneration.

Authors:  Hui Zhao; Jayeeta Roychoudhury; Teresa A Doggett; Rajendra S Apte; Thomas A Ferguson
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-07       Impact factor: 4.799

3.  Targeting immune privilege to prevent pathogenic neovascularization.

Authors:  Jayeeta Roychoudhury; John M Herndon; Jiyi Yin; Rajendra S Apte; Thomas A Ferguson
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-02-17       Impact factor: 4.799

4.  Suppression of FasL expression in tumor cells and preventing TNF-induced apoptosis was better for immune cells survival.

Authors:  Gaosi Xu; Jiangguo Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2008-05-07       Impact factor: 4.553

Review 5.  Inflammation and its role in age-related macular degeneration.

Authors:  Anu Kauppinen; Jussi J Paterno; Janusz Blasiak; Antero Salminen; Kai Kaarniranta
Journal:  Cell Mol Life Sci       Date:  2016-02-06       Impact factor: 9.261

6.  Understanding the Effects of Age and T-Cell Differentiation on COVID-19 Severity: Implicating a Fas/FasL-mediated Feed-Forward Controller of T-Cell Differentiation.

Authors:  Anthony J Leonardi; Christos P Argyropoulos; Adam Hamdy; Rui B Proenca
Journal:  Front Immunol       Date:  2022-03-03       Impact factor: 7.561

7.  Fas ligand mediates immune privilege and not inflammation in human colon cancer, irrespective of TGF-beta expression.

Authors:  A Houston; M W Bennett; G C O'Sullivan; F Shanahan; J O'Connell
Journal:  Br J Cancer       Date:  2003-10-06       Impact factor: 7.640

8.  FAS/FASL are dysregulated in chordoma and their loss-of-function impairs zebrafish notochord formation.

Authors:  Luca Ferrari; Anna Pistocchi; Laura Libera; Nicola Boari; Pietro Mortini; Gianfranco Bellipanni; Antonio Giordano; Franco Cotelli; Paola Riva
Journal:  Oncotarget       Date:  2014-07-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.